Validity, reliability, responsiveness, and clinically meaningful change threshold estimates of the National Comprehensive Cancer Network-Functional Assessment of Cancer Therapy-Breast Cancer Symptom Index (NFBSI-16).
Nathan A ClarkeBrendon WongRachael LawranceAnders IngelgårdIngolf GriebschDavid CellaAndrew TriggPublished in: Journal of patient-reported outcomes (2024)
This study provides evidence that the NFBSI-16 has desirable psychometric properties for use in clinical studies in aBC. It also provides estimates of group- and individual-level meaningful change thresholds to facilitate score interpretation in future aBC research.